Large Rise in Earnings Reported by HemaCare
- Share via
HemaCare Corp. said its earnings more than tripled to $178,657 in the first quarter that ended March 31 from $55,491 a year earlier.
The Sherman Oaks company, which sells blood products and provides blood banking, said its revenue rose 19% to $1.3 million. The company’s earnings rose mainly because of a big jump in providing hemapheresis, or blood treatment services, in the Los Angeles area.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
